Document is current
Any future updates will be listed below
-
Authors
Ma, Xiu-Wei
Jiang, Xin-Yang
Li, Zhong-Qiu
Dong, Xiao-Yan
Ma, Wen-Hao
Wang, Yong-Xia
Yu, Shuang-Qing
Gu, Rui-Jie
Wang, Xiao-Dong
Zhong, Bai-Mao
He, Fang
Xu, Juan
Mao, Ying-Ying
Zhang, Yan-Ping
Zhang, Shan
Li, Ting
Li, Chong-Yang
Zhang, Sheng
Yang, Xiao
Zhu, Li-Na
Wu, Zhi-Jie
Zhou, Bing
Zhuang, Lu
Li, Qiu-Ping
Wu, Xiao-Bing
Feng, Zhi-Chun https://orcid.org/0000-0002-9622-4062
-
Funding
Funding for this research was provided by:
E-Town Cooperation & Development Foundation (YCXJ-JZ-2022-007)
- License Information
-
More Information
Article History
Received: 24 March 2025
Revised: 2 July 2025
Accepted: 7 July 2025
First Online: 4 August 2025
Declarations
:
: The research protocol was approved by the Ethics Committee of the Seventh Medical Center of the Chinese PLA General Hospital (Beijing, China; S2022-001-04). The study protocol is available at Chictr.org.cn (ChiCTR2100054441). Written informed consent was obtained from the patients’ parents or guardians before enrollment.
: MWH, WXD, YSQ, MYY, and WZJ are employees of Genecradle Therapeutics Inc. during the study. DXY is the co-founder of Genecradle Therapeutics Inc. during the study. WXB is the founder of Genecradle Therapeutics Inc. during the study. MWH, WXB, and DXY have a patent. All the other authors declare no competing interests.
